Peter Campochiaro, MD
Disclosures: Consulting Fee-Aerpio Therapeutics,Consulting Fee-Allergan,Consulting Fee-Applied Genetic Technologies,Consulting Fee-AsclipiX,Consulting Fee-Genentech, Inc.,Consulting Fee-Rxi,Consulting Fee-Merck and Company, Inc.,Consulting Fee-Allegro,Contracted Research-Regenxbio-Principal_Investigator,Contracted Research-Allergan-Principal_Investigator,Contracted Research-Aerpio Therapeutics-Principal_Investigator,Contracted Research-Genentech, Inc.-Principal_Investigator,Contracted Research-Genzyme Corporation-Principal_Investigator,Contracted Research-Oxford BioMedica-Principal_Investigator,Regeneron-Principal_Investigator,Consulting Fee-Exonate,Consulting Fee-Novartis AG,Contracted Research-AsclipiX-Principal_Investigator,Consulting Fee-Graybug,Ownership Interest-Graybug,Contracted Research-Clearside-Principal_Investigator
No Bio Available.